Sanderling Venture Partners VI LP Insider Trading
Get free email notifications about insider trading for Sanderling Venture Partners VI LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sanderling Venture Partners VI LP. Sanderling Venture Partners VI LP is a Director in Pacira Pharmaceuticals, Inc. ($PCRX).
Address: 400 SOUTH EL CAMINO REAL SUITE 1200 SAN MATEO 94402 CA
Companies in which Sanderling Venture Partners VI LP is an Insider
Pacira BioSciences, Inc.
Trading Symbol: PCRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sanderling Venture Partners VI LP: Director
Holdings: 416,083 shares
Current Value: $17,371,465
Latest Transaction: Mar 20 2013
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Sanderling Venture Partners VI LP
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 20 2013 | PCRX | Pacira Pharmaceuti ... | Sanderling Venture Partners VI ... | Director | Sell | S | 26.95 | 46,339 | 1,248,836 | 416,083 | 462.4 K to 416.1 K (-10.02 %) |
Mar 20 2013 | PCRX | Pacira Pharmaceuti ... | Sanderling Venture Partners VI ... | Director | Sell | S | 27.66 | 38,250 | 1,057,995 | 462,422 | 500.7 K to 462.4 K (-7.64 %) |
Mar 20 2013 | PCRX | Pacira Pharmaceuti ... | Sanderling Venture Partners VI ... | Director | Sell | S | 28.19 | 29,415 | 829,209 | 0 | 29.4 K to 0 (-100.00 %) |
Mar 20 2013 | PCRX | Pacira Pharmaceuti ... | Sanderling Venture Partners VI ... | Director | Sell | S | 28.19 | 24,688 | 695,955 | 0 | 24.7 K to 0 (-100.00 %) |
Mar 20 2013 | PCRX | Pacira Pharmaceuti ... | Sanderling Venture Partners VI ... | Director | Sell | S | 28.19 | 29,825 | 840,767 | 500,672 | 530.5 K to 500.7 K (-5.62 %) |
Mar 20 2013 | PCRX | Pacira Pharmaceuti ... | Sanderling Venture Partners VI ... | Director | Sell | S | 29.20 | 28,558 | 833,894 | 29,415 | 58 K to 29.4 K (-49.26 %) |
Mar 20 2013 | PCRX | Pacira Pharmaceuti ... | Sanderling Venture Partners VI ... | Director | Sell | S | 29.20 | 23,969 | 699,895 | 24,688 | 48.7 K to 24.7 K (-49.26 %) |
View all Sanderling Venture Partners VI LP insider transactions.